Skip to main content
2023 AANS Annual Scientific Meeting Main banner
Back

Eve Tsai, MD, PhD

Suruchi Bhargava Chair in Spinal Cord and Brain Regeneration
The Ottawa Hospital, University of Ottawa
Ottawa, Ontario, Canada

Dr. Eve Tsai MD, PhD, CIP, FRCSC gained early acceptance into medical school and obtained her medical degree from the University of Toronto. She then completed her neurosurgery residency training at the University of Toronto. During her residency, she completed a PhD in spinal cord repair. Dr. Tsai then obtained subspecialty training in spine surgery and completed a Spine Fellowship at The Cleveland Clinic. She has won numerous clinical, research, teaching and humanitarian awards.

In both 2011, 2012 and 2014, Dr. Tsai was selected by committee as one of the Top 25 Women of Influence by Women of Influence Magazine (the only woman who has had the honor of winning thrice). She was also chosen as the winner of the Health Section Category and is the only woman to have won the cover of the magazine for two years in a row. The cover was selected by the most online votes. http://www.womenofinfluence.ca/magazine/. In 2010, she won Canada’s Top 40 Under 40 AwardTM, which honours achievement for vision and leadership; innovation and achievement; impact; growth/development strategy; and community involvement and contribution. She has also won the AANS Young Clinician Investigator Award in 2008.

She is currently the holder of the Suruchi Bhargava Spine and Brain Regeneration Chair and an internationally recognized academic neurosurgeon. Her main surgical interests focus on all types of spine and spinal cord diseases such as: spinal cord injury, spinal cord and spine tumors, syringomyelia, and myelopathy. Her research focuses on spinal cord repair strategies, neural and axonal regeneration, MRI imaging of spinal cord tracts in humans and animals, and clinical outcomes after spine surgery. She is an expert in the rodent spinal model, and her basic science research background allows her to critically evaluate preclinical studies and carefully select promising therapies that could be clinically applied successfully.

Presentation(s):